Renk's Stock Caught Between NATO Windfall and Hedge Fund Bets

Shares in German defense supplier Renk Group advanced 1.13% to EUR 53.90 on Friday, extending a week-long recovery. The move came as the company secured a major new NATO contract, yet the stock remains nearly 40% below its yearly high, caught between a record order book and mounting skepticism from short sellers.

The Augsburg-based specialist for tank transmissions announced a deal worth approximately EUR 157 million to supply drive systems to a NATO member state. Deliveries for the contract, which will power the K2 Panther battle tank, are scheduled from late 2026 through 2033. This order further solidifies Renk's massive backlog, which stands at roughly EUR 6.7 billion. Poland is currently undertaking a significant military expansion with this tank model, and further licensed production in a neighboring country is considered likely.

Despite this operational strength, the stock is showing signs of being heavily oversold, with a Relative Strength Index reading of 29.3. This disconnect has attracted prominent short sellers. Hedge fund AQR Capital Management recently increased its net short position to 2.30% of Renk's outstanding shares. The skepticism stems from execution challenges. The company is grappling with timing shifts on major contracts, with around EUR 200 million in planned revenues pushed into the first half of 2026. Furthermore, its cash generation has been weak. Free cash flow recently reached only EUR 67 million, with a cash conversion rate of just 47%, missing management's original target of 80%.

Analysts, however, see substantial upside, painting a starkly different picture from the short sellers. The consensus view suggests a potential share price appreciation of more than 30%. DZ Bank has set a price target of EUR 65, while JPMorgan maintains an "Overweight" rating with a EUR 75 target. Their bullish outlook is predicated on an expected margin expansion as Renk scales its production toward modularized small-series manufacturing.

This strategic shift in production is a double-edged sword. While it promises better long-term profitability, the costly restructuring is currently weighing on margins and consuming capital. Geopolitical tensions add another layer of risk. An extended embargo on business with Israel could jeopardize planned revenues of up to EUR 100 million for the current year, potentially forcing a revision of annual guidance.

Investors are now looking to several key dates for clarity. A pre-close call on April 22 will provide early indications for the current quarter, with a specific focus on the receipt of delayed advance payments. The official first-quarter figures, to be presented on May 6, 2026, will deliver concrete facts on delivery capabilities and cash flow. For the full year, management is targeting group revenue of over EUR 1.5 billion and an operating result of around EUR 270 million. Whether Renk hits these goals depends on its ability to overcome current delays. Strong results could squeeze the short sellers, while a miss would likely see them increase their bets.

Ad

Renk Stock: New Analysis - 17 April

Fresh Renk information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Renk analysis...

Ad

Renk's Stock: New Analysis - 17 April

Fresh Renk's information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Renk's analysis...